Comirnaty for 5 to 11 years old (Note 2) (bivalent, Original/Omicron BA.4-5) Partial Change Approval
Coronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredients: tozinameran and famtozinameran)
Approval Information
Brand NameComirnaty for 5 to 11 years old (Note 2)
(bivalent, Original/Omicron BA.4-5)
Partial Change Approval
Generic NameCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2)
(active ingredients: tozinameran and famtozinameran)
ApprovedFebruary 2023
TypeInitial Approval
Review Reports
Want structured data, translation summaries & alerts?
PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.
Join the WaitlistSource: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.